BridgeMD
New treatment option for Vaccination; Infection
Official title Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
ClinicalTrials.gov ID: NCT06907667
What this study is testing
- What it's testing
- Immune response to influenza vaccine in patients with chronic renal insufficiency.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \< 30mL/min/1.73m2); or Dialysis patient; or renal transplant patient regardless of...
- Age ≥ 18 years;
- Indication for influenza vaccination;
- Express free and informed consent.
You likely can't join if
- Known hypersensitivity to influenza vaccine or egg proteins;
- Previous influenza vaccination for the current season;
- Current infection;
- Current acute illness;
- Treatments with a major impact on vaccine response:
- Treatment of rejection within the previous 3 months;
See the full eligibility criteria
- Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \< 30mL/min/1.73m2); or Dialysis patient; or renal transplant patient regardless of GFR;
- Age ≥ 18 years;
- Indication for influenza vaccination;
- Express free and informed consent.
- Known hypersensitivity to influenza vaccine or egg proteins;
- Previous influenza vaccination for the current season;
- Current infection;
- Current acute illness;
- Treatments with a major impact on vaccine response:
- Treatment of rejection within the previous 3 months;
- Renal transplantation with induction performed within the previous 6 months;
- Immunosuppressive treatment including CTLA4 agonist, complement inhibitor, anti-CD20;
- Treatments that may distort the serological response: Polyvalent immunoglobulin infusion within the preceding 3 months;
- Vulnerable persons (minors, adults under guardianship or trusteeship, persons deprived of their liberty, persons unable to speak French);
- people not affiliated to Social Security.
The study team makes the final eligibility decision.
Where it's taking place
- Nice, Alpes-Maritimes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, Alpes-Maritimes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.